Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL502559 | 0.88 | ALDH1A1 (0.43) | ALDH1A1LMNAHSD17B10TSHR | |
| SCHEMBL487332 | 0.88 | ALDH1A1 (0.43) | ALDH1A1LMNAHSD17B10TSHR | |
| SCHEMBL487241 | 0.88 | ALDH1A1 (0.43) | ALDH1A1LMNAHSD17B10TSHR | |
| SCHEMBL3915176 | 0.86 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10TSHR | |
| SCHEMBL3911401 | 0.86 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10TSHR | |
| SCHEMBL487271 | 0.80 | ALDH1A1 (0.44) | ALDH1A1LMNAHSD17B10TSHR | |
| SCHEMBL3912403 | 0.80 | ALDH1A1 (0.44) | ALDH1A1LMNAHSD17B10TSHR | |
| SCHEMBL487443 | 0.80 | ALDH1A1 (0.44) | ALDH1A1LMNAHSD17B10TSHR | |
| SCHEMBL3912674 | 0.78 | ALDH1A1 (0.42) | ALDH1A1TSHR | |
| SCHEMBL3909306 | 0.78 | ALDH1A1 (0.42) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260118791-A1 | TONER | CANON KK (JP) | 2026-04-30 | — | — | US | disclosed |
| CN-111381467-B | Toner and method for producing toner | 佳能株式会社 | 2024-06-14 | — | — | CN | disclosed |
| CN-111381461-B | Toner and method for producing the same | 佳能株式会社 | 2024-04-23 | — | — | CN | disclosed |
| CN-111381462-B | Toner and method for producing the same | 佳能株式会社 | 2024-04-16 | — | — | CN | disclosed |
| EP-0823928-B1 | GONIOCHROMATIC BRIGHT PIGMENTS WITH A METAL SULPHIDE-CONTAINING COATING | BASF AG (DE) | 2001-03-07 | — | — | EP | disclosed |
| EP-0708154-B1 | Brilliant metallic pigments bearing several coatings | BASF AG (DE) | 2000-03-15 | — | — | EP | disclosed |
| EP-0741170-B1 | Brilliant goniochromatic pigments having an aluminium coating | BASF AG (DE) | 1999-12-29 | — | — | EP | disclosed |
| EP-0708155-B1 | Process for manufacturing solic particles coated with silicon dioxide | BASF AG (DE) | 1999-09-01 | — | — | EP | disclosed |
| US-5733364-A | Goniochromatic luster pigments with aluminum coating | BASF AKTIENGESELLSCHAFT (DE) | 1998-03-31 | — | — | US | disclosed |
| EP-0823928-A1 | GONIOCHROMATIC BRIGHT PIGMENTS WITH A METAL SULPHIDE-CONTAINING COATING | BASF AKTIENGESELLSCHAFT (DE) | 1998-02-18 | — | — | EP | disclosed |
| US-5607504-A | Multiply coated metallic luster pigments | BASF AKTIENGESELLSCHAFT (DE) | 1997-03-04 | — | — | US | disclosed |
| WO-1996034917-A1 | GONIOCHROMATIC BRIGHT PIGMENTS WITH A METAL SULPHIDE-CONTAINING COATING | BASF AKTIENGESELLSCHAFT (DE) | 1996-11-07 | — | — | WO | disclosed |
| EP-0741170-A1 | Brilliant goniochromatic pigments having an aluminium coating | BASF AKTIENGESELLSCHAFT (DE) | 1996-11-06 | — | — | EP | disclosed |
| EP-0708154-A2 | Brilliant metallic pigments bearing several coatings | BASF AKTIENGESELLSCHAFT (DE) | 1996-04-24 | — | — | EP | disclosed |
| EP-0708155-A2 | Process for manufacturing solic particles coated with silicon dioxide | BASF AKTIENGESELLSCHAFT (DE) | 1996-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260118791-A1 | TONER | MSR1, H1-2, TAAR1 | ALDH1A1 2569/4885LMNA 1670/4885HSD17B10 2394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.